Amyotrophic lateral sclerosis (ALS) is a devastating late-onset neurodegenerative disorder in 20 which only a small proportion of patients carry an identifiable causative genetic lesion. Despite 21 high heritability estimates, a genetic etiology for most sporadic ALS remains elusive. Here we 22 report the epigenetic profiling of five monozygotic twin pairs discordant for ALS in whom 23 previous genome sequencing excluded a genetic basis for their disease discordance. By studying 24 cytosine methylation patterns in peripheral blood DNA we identified thousands of large 25 between-twin differences at individual CpGs. While the specific sites of difference were largely 26 idiosyncratic to a twin pair, a proportion (involving GABA signalling) were common to all 27 affected individuals. In both instances the differences occurred within genes and pathways 28 related to neurobiological function and dysfunction. Our findings reveal widespread changes in 29 epigenetic marks in ALS patients, consistent with an epigenetic contribution to disease. These 30 findings may be exploited to develop blood-based biomarkers of ALS and develop further 31 insight into disease pathogenesis. We expect that our findings will provide a useful point of 32 reference for further large-scale studies of sporadic ALS. 33
Introduction

46
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is a lethal adult-onset 47 disease that causes progressive muscle weakness, with death usually 2 to 5 years after initial 48 diagnosis [1] . About 10% of ALS is familial and attributable to germline mutation of specific 49 genes, but in the majority of cases (~90%) no other family member is affected, and the cause of 50 most of this so-called sporadic form of ALS (SALS) remains unknown. Genetic, epigenetic and 51 environmental factors have all been suggested to play a role in SALS, with combinations of these 52 factors proposed to contribute to a multi-staged etiology [2] . 53
Although rare single or multiple genetic variants may underlie some cases of SALS [3, 4] , much 54 of the heritability of the disease remains to be found [5] . Attention has turned to the possibility 55 that epigenetic factors could contribute to ALS and its associated condition, frontotemporal 56 dementia [6] . The fact that epigenetic changes may be therapeutically modified has driven 57 research in this area [7] . A limited number of unvalidated epigenetic studies of SALS have been 58 undertaken, involving single genes such as SOD1 and VEGF [8] , small groups of genes such as 59 those in the metallothionein family (involved in detoxifying heavy metals) [9] , and genome-wide 60 methylation analysis using microarray [10] . However, the role of epigenetic variants in SALS 61 remains unclear and largely unexplored [11] . 62 4 Assessing the epigenetic basis of any disease in outbred populations such as humans is difficult 63 since benign genetic variation is a major confounder [12] . Furthermore, there is the additional 64 challenge of distinguishing germline epigenetic abnormalities from somatic changes secondary 65 to either pre-or post-natal environmental influences [13] . This is particularly relevant to standard 66 case-control studies because a vast number of environmental influences come into play within a 67 normal human lifetime. One way of addressing this variability between subjects is to study 68 disease-discordant monozygotic twins, who share at least the same genome, are exposed to a 69 parallel intrauterine environment, and often have similar lifestyles. This is an appealing approach 70 for ALS since twin registry studies show ALS is discordant in over 90% of monozygotic twins 71 [14] [15] [16] , which implies a major epigenetic or environmental component in disease susceptibility. 72
Epigenetic differences certainly exist between monozygotic twins [17] , and attempts have been 73 made to link such co-twin differences to disorders as diverse as psoriasis [18] , neurofibromatosis 74 [19] , and frontometaphyseal dysplasia [20] . 75
In this study we explored the nature and extent of epigenetic changes in peripheral blood DNA 76 from five sets of well-characterised ALS-discordant monozygotic twins. We compared genomic 77 DNA methylation patterns between these twins in both case-control and co-twin analyses. We 78 found a large number of differentially methylated sites between twins, most of which occurred at 79 isolated CpGs, which cluster in common genes and pathways relating to neurobiological 80 functions. 81
Results
82
Monozygotic twins discordant for ALS show no evidence of germline epimutation at known 83
ALS genes 84 5 Ten individuals were included in this study: five individuals with a diagnosis of sporadic ALS, 85
and their respective unaffected monozygotic twin siblings ( Table 1 ). The average difference in 86 time between ALS onset in the affected twin and the current age of the unaffected twin was 8.4 87 years (range 7-10 years), implying a non-genetic etiology of ALS in the affected twin. 88
Consistent with this, none of the twins harboured an expanded repeat at the C9orf72 locus [21] . 89 Furthermore, previous whole genome sequencing failed to detect any other significant genetic 90 variation between these co-twins; no pathogenic point mutation, insertion/deletion, or structural 91 alteration was identified in the affected twins when compared with their unaffected co-twin [22] . 92
We therefore considered the possibility that the underlying predisposing defect in the affected 93 twins may be epigenetic in nature: epigenetic differences are not uncommon between 94 monozygotic twins, and available evidence suggests that many such differences may be present 95 from birth [17] . We obtained representative cytosine methylation profiles on peripheral blood 96 DNA for each individual using Illumina 450K Infinium methylation arrays [23] and reduced 97 representation bisulfite sequencing (RRBS) [24] . The 450K array assesses methylation at a pre-98 determined set of ~450,000 single CpG sites concentrated around gene promoters and gene 99 bodies. RRBS assesses ~1% of the genome and ~1 million or more CpGs; it is complementary to 100 the 450K array since it also captures many CpGs outside of CpG islands and allows allelic 101 resolution of methylation patterns. In our RRBS libraries we obtained >10x coverage on an 102 We first sought evidence for aberrant methylation in the affected twins at promoters of the ALS-111 associated genes ALS2, C9orf72, FUS, OPTN, PFN1, SETX, SOD1, SPG11, TARDBP, VAPB, 112 VCP and UBQLN2 [25] . We found no evidence of hypermethylation at probes within any known 113 ALS gene promoter in any twin in the 450K array data. Further, at 10x coverage our RRBS 114 libraries captured allelic information on the promoters of the same genes in all twin pairs, but 115 none of the affected twins exhibited aberrant methylation at any of these loci (Fig 1A) . Patterns 116 of methylation at each known ALS disease locus were almost identical among all individuals, 117 with all autosomal promoters showing little to no methylation, as shown for example in C9orf72 118 (Fig 1B) . Thus, the discordance for ALS in these monozygotic twin pairs is not due to a germline 119 genetic or epigenetic defect in any of the genes commonly associated with familial ALS. 7
Case-control analysis of methylation implicates GABA receptor signalling as a commonly 121 perturbed epigenetic network in ALS 122
We next took an unbiased approach to determining whether epigenetic differences may underlie 123 the twin discordance for ALS. Unsupervised hierarchical clustering of RRBS data at 10x did not 124 separate cases and controls, but instead identified five distinct clusters representing the five twin 125 pairs (Fig 2A) . This is not surprising given the known influence of genotype on inherited 126 methylation patterns [26] . We then used the statistical package methylKit [27] to ask whether 127 there were any differentially methylated CpG sites (DMCs) in common between all ALS cases 128 versus all unaffected controls. At a significance threshold of q<0.01, this identified 135 CpG 129 sites with ≥ 20% average difference in methylation between the two groups ( Fig 2B; Table S2 ). 130
About one half of these DMCs were in unannotated, intergenic regions of the genome, with the 131 remainder predominantly within intronic regions (Fig 2C) . Unsupervised clustering of the 450K 132 data led to a similar clustering by twin pair, not disease status (Fig 2D) . Analysis of the array 133 data using minfi [28] failed to identify any significant common DMCs; CpGs with nominal 134 significance, or approaching significance after correction for multiple testing, exhibited only tiny 135 differences in methylation between cases and controls (Fig 2E) . 136
None of the common DMCs identified by the RRBS case-control analysis exhibited changes 137 consistent with a germline event (i.e. affecting most or all cells). On average the differences 138 between cases and controls were ±25%, and while mosaicism for a germline change cannot be 139 ruled out in this study of a single tissue, it is more likely that these modest changes indicate 140 common somatic changes in ALS-affected individuals that are consequent to their disease. 141 Ingenuity Pathway Analysis [29] (IPA) of the genes harbouring DMCs (n=74) revealed 142 enrichment for several pathways, the most significantly enriched being 'GABA receptor 143 8 signalling' (Fig 2F) . IPA also identified four gene networks in which the affected genes function 144 ( Fig S1) . The network containing genes involved in GABA signalling, shown in Fig 2G, centred  145 around TNF. The other three pathways (two headed by cancer, and one by lipid metabolism) 146 ( Fig S1) have no obvious pathogenetic link to ALS, but since so little is known about the cause 147 of ALS these networks warrant further investigation. 148
Outlier analysis of RRBS data reveals characteristic epigenetic differences between ALS 149 affected and unaffected twins 150
While the RRBS case-control analyses revealed interesting changes common to all twins, the 151 necessary grouping of individuals for analysis means large changes of potential biological 152 significance in only one or two ALS-affected individuals would be lost to statistical analysis. 153
The 'power of the twin' would also be lost; this is particularly relevant in epigenetic studies, 154
where underlying DNA sequence can influence or even determine epigenetic state [30] . Given 155 the clinical and genetic heterogeneity of ALS, the pathogenesis of motor neuron loss may be 156 distinct in each affected twin. RRBS methylation patterns were therefore compared between each 157 affected and unaffected individual in co-twin analyses. 158
We began by performing a Pearson's correlation of methylation levels between co-twins. 159
Co-twin CpG methylation was highly correlated overall (r=0.978, range 0.972-0.982), and 160 showed a generally bimodal distribution with most sites being either heavily methylated or 161 largely unmethylated (Fig 3A) . CpG sites present at >20x coverage in both twins within a pair 162 were considered for further analysis. Those CpGs ≥ 5 residuals from the expected value from a 163 linear model of all sites were called as methylation 'outliers' (Fig 3B) . The minimum magnitude 164 of difference in methylation at outliers between co-twins at this stringent cut-off was ~40%. 165
Using this approach we identified more than 1,000 methylation outliers in each twin pair ( Fig  166  3C ; Table S3 ). Although there was a preponderance for methylation outliers to be 167 hypomethylated in the ALS twins relative to the non-ALS twins, whole genome levels of 5-168 methylcytosine as measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) 169 did not differ between affected and unaffected individuals (Fig 3D) , as has been previously 170 suggested for ALS [31] . 171
Genomic annotation of the outliers showed that, relative to all sites captured by RRBS, outlier 172 sites were less likely to be in a CpG island (Fig 3E) . Like the common DMCs identified by 173 methylKit, outlier sites were predominantly in intronic and intergenic regions (Fig 3F) . The 174 majority of outlier CpGs were idiosyncratic to a twin pair, with little overlap among the twin 175 pairs (Fig 3G) . But when considering the genes harbouring the outlier CpG sites, the overlap 176 among twins was greater, with ten genes (ABR, NCOR2, SORCS2, HDAC4, SHANK2, RBFOX3, 177 RXRA, MAD1L1, PTPRN2, GRIN1) harbouring one or more methylation outliers in all five twin 178 pairs (Fig 3H) . Despite this overlap at the gene level, at least half of the affected genes were 179 unique to a twin pair. 180
ALS methylation outliers cluster in disease-relevant ontologies and pathways 181
We next took the genomic coordinates of the outlier CpGs and used the Genomic Regions 182 Enrichment of Annotations Tool (GREAT) [32] to identify the ontologies of the sets of outliers 183 for each twin pair. The molecular functions overrepresented by the outliers had one ontology in 184 common across all twin pairs, 'sequence specific DNA binding' ( Table 2) . This is not disease-185 specific, but suggests that genes encoding transcription factors are susceptible to varying in 186 epigenotype between identical genotypes. The significantly enriched biological functions 187 revealed a large number of associated ontologies (Table S4) Table 3) . Cellular compartment ontologies of the outliers were 191 significantly enriched in three of the five twin pairs, all of which share a 'Golgi lumen' 192 compartment enrichment ( Table 4 ). Golgi fragmentation is a well-recognised early event in 193 multiple in vitro and animal models of ALS [33] . 194 IPA analysis of the genes harbouring methylation outliers produced a set of top canonical 195 pathways for each twin pair (Table S5 ). Cross-comparison of enriched pathways across all twin 196 pairs revealed many significantly enriched pathways in common between two or more twin pairs 197 (Fig 4) . Most striking were the commonalities among neurobiological pathways, including 198 pathways such as synaptic long-term potentiation. Taken together with the ontology analysis, this 199 suggests that many methylation outliers represent an epigenetic signature of ALS in peripheral 200 blood. 201 Table S4 205 206 
Discussion
209
We have taken advantage of the genetic and early environmental similarity of identical twins 210 discordant for ALS to gain insight into the nature and extent of epigenetic changes in this 211 disease. Together our findings demonstrate that ALS has epigenetic signatures in peripheral 212 blood DNA that could potentially be exploited as biomarkers of disease. Our findings are 213 consistent with widespread disruptions to epigenetic patterns in ALS that either underlie disease 214 etiology, or represent changes consequent to pathology. 215
Familial ALS is genetically heterogeneous, but clinically very similar to SALS, which prompted 216 us to use our data to first examine methylation at genes known to be mutated in familial ALS. 217 Germline epimutation, characterised by soma-wide aberrant silencing of a gene, can phenocopy a 218 genetic mutation [34] , and is usually associated with dense hypermethylation at the promoter of 219 the affected gene. However none of the individuals exhibited any aberrant methylation at known 220 14 ALS gene promoters in their peripheral blood. This finding does not necessarily preclude an 221 inborn epigenetic defect as the basis for an affected twin's predisposition to ALS, but it excludes 222 this possibility at known ALS genes. 223
Unbiased case-control analyses are designed to detect commonalities between groups. It is of 224 particular interest that our RRBS analyses revealed affected twin-concordant methylation 225 changes at genes that cluster in GABA receptor signalling. Cortical hyperexcitability is one of 226 the earliest identifiable changes in patients with ALS, caused at least in part by degeneration of 227 inhibitory cortical circuits and reduced cortical GABA levels [35, 36] . Given that ALS is such a 228 heterogeneous disease [37] , these epigenetic changes common to all our ALS affected twins 229 could be to secondary to the many pathogenetic pathways found in ALS, rather than being 230 causally related to the disease. If so, these changes hold the potential to be exploited as blood-231 based biomarkers for an early diagnosis of ALS. 232
When considering methylation differences between twins we found a considerable number of 233 differences of large magnitude and defined these as 'methylation outliers'. Based on the 234 magnitude of difference in methylation between co-twins at outliers and the stringent parameters 235 we used to identify them, it is unlikely that these outliers merely reflect experimental noise. We 236 do not expect, however, that all methylation outliers between co-twins will be representative of 237 ALS discordance, since many differences may reflect or underlie other phenotypic discordances, 238 or individual exposure to environmental factors [12] . For example, one of our individuals was a 239 smoker at the time of sample collection and her co-twin was not; in this pair we were able to 240 identify the expected difference in methylation levels at an intronic CpG in the AHRR gene, 241 known to robustly associated with active smoking [38] (Fig S2) . This particular difference fell 242 just under our outlier threshold of ≥ 5 residuals, but given that twin pairs carry thousands of 243 15 outlier sites of greater magnitude than this, at least some of them will be expected to reflect the 244 discordance for ALS, a supposition supported by the gene ontology and pathway analyses of 245 outliers. Genome-wide analyses of outliers identified in healthy twins (performed in a similar 246 manner [12] ) revealed between-twin differences that cluster largely in ontologies related to the 247 tissue being examined; between-twin DMCs in adipose tissue clustered in functions related to 248 lipid metabolism while peripheral blood DMCs clustered in haematological functions [12] . 249
The thousands of outlier sites we identified in each twin pair showed only a modest overlap in 250 genes affected, but all five twin pairs harboured outliers in ten common genes. Three of these 251 genes have previously been implicated in ALS: SORCS2, RXRA, and HDAC4, which have 252 prominent roles in inflammation and epigenetic regulation [39] [40] [41] . GRIN1, another of the ten 253 common genes, encodes a subunit of the glutamate NMDA receptor, the major mediator of 254 excitotoxicity; splicing of GRIN1 requires the RNA binding protein TAF15, another molecule 255 implicated in ALS [42] . The remaining genes, including ABR, SHANK2, RBFOX3 and PTPRN2 256 have no obvious link to ALS, but are notable for being highly expressed in the central nervous 257 system. The genes which are affected in all our cases could be considered candidates in follow-258 up studies of larger SALS cohorts. 259
The overlap in functional pathways and networks associated with ALS methylation outliers was 260 the most striking finding of this study. Neurobiological functions or pathways relevant to ALS 261 were overrepresented in every twin pair, even with the modest lack of gene overlap, and more 262 importantly, with the tissue that was examined (white blood cells, not CNS). We were not able to 263 adjust for blood cell composition but such differences, if present, would not be expected to result 264 in enrichment for neurobiological-related ontologies. Perturbed neuro-related pathways in non-265 affected tissue might reflect different routes to the common endpoint of ALS in each affected 266 16 twin; these could potentially be germline epigenetic changes that have predisposed to ALS, but 267
we are unable to establish this as other normal tissues were not available for analysis. On the 268 other hand, it is equally plausible (if not more likely) that the idiosyncratic CpG outliers in 269 affected twins are representative of different environmental exposures, some of which have 270 contributed to ALS susceptibility. Assessing larger cohorts of sporadic ALS for the presence of 271 the outliers identified in this study may yield greater insight into their role in ALS. 272
A noteworthy finding of this study is that the differences we identified with RRBS could not be 273 detected with the 450K array, because the majority of ALS methylation outliers we found are not 274 represented on the array. While the 450K array has been a popular method for epigenetic 275 epidemiology due to its low cost and ease of analysis, our results show that the representative set 276 of CpGs on the array are less than optimal in capturing the extent of epigenetic variation in ALS. 277 RRBS captures only around 1% of the genome (although enriched for CpGs), but with the 278 increasing affordability of high-throughput sequencing, whole genome bisulfite sequencing 279 (WGBS) of large cohorts will soon be become feasible. Our results suggest that future WGBS 280 studies will be required to capture the full extent of epigenetic discordance among identical twins 281 with discordant disease phenotypes. 282 differences between the co-twins are shown in Table 1 . Venous blood samples were taken from 297 an antecubital vein at the same time in each twin pair. DNA was extracted from white blood cells 298 using the QIAmp blood kit (Qiagen) and stored at -20°C until used. 299
Materials and Methods
Total 5-methylcytosine (5mc) content 300
Total 5mc content of each DNA sample was analysed by liquid chromatography-mass 301 spectrometry (LC-MS/MS). Approximately 1 µg of genomic DNA was used in hydrolysis using 302 DNA Degradase Plus (Zymo). The reaction mixture was incubated at 37°C for two hours to 303 ensure complete digestion prior to LC-MS/MS, as described previously [43] . 304
Reduced representation bisulfite sequencing (RRBS) 305
Indexed RRBS libraries were prepared from 1µg of MspI-digested genomic DNA essentially as 306 described [24] , and sequenced in multiplex on the Illumina HiSeq 2000. Resulting fastq files 307 were trimmed with cutadapt v1.3. Trimmed reads were aligned to the human reference genome 308 (hg19) using Bismark v0.10.0 [44] paired with Bowtie v1 [45] with default parameters with 309 methylation calling by Bismark-methylation-extractor. Output files were reformatted for direct 310 input into methylKit using a custom script. 311
RRBS case-control analysis 312
Differentially methylated CpG sites between all cases and controls were identified using the 313
Bioconductor R package methylKit [27] with filter settings of ≥ 20X coverage, ≥ 20% 314 methylation difference, and q value of 0.01. 315
Outlier analysis 316
Linear models were established using R for each twin pair using methylation calls for CpG sites 317 in common to co-twins with ≥ 20x coverage. Outlier CpG sites were defined as those ≥ 5 residuals 318 from the predicted value from the linear model. Genomic coordinates for outlier sites for each 319 twin pair were analysed with the gene ontology software GREAT [32] . Genes harbouring 320 outliers were analysed further by Ingenuity Pathway Analysis (http://www.ingenuity.com/). 321
Illumina Infinium 450K arrays 322
Infinium 450K arrays were performed on each sample by the Australian Genome Research 323 Facility (http://www.agrf.org.au/). Resultant data were analysed using the Bioconductor package 324 minfi [28] using SWAN normalisation. Only probes with a detection value of p value <0.01 were 325 included in analysis. 326
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